Reports
Reports
Realize The True Potential Of Therapeutic Area
Total Reports: 111
The Peripheral Arterial Disease (PAD) treatment drugs market is anticipated to witness steadiness, in line with the rising incidence of PAD owing to increasing incidence of diabetes, obesity, and hypertension.
Rep Id : TMRGL86559 | Published | Healthcare | March 2025
The growing awareness of women's health, along with advancements in personalized medicine, is expected boost the raloxifene hydrochloride market value. Raloxifene hydrochloride is an oral medication primarily used for the prevention of osteoporosis in postmenopausal women. It is also prescribed to prevent and treat invasive breast cancer. Sold under the
Rep Id : TMRGL86534 | Published | Healthcare | March 2025
The global urea cycle disorder (UCD) treatment market is poised for significant growth, driven by key factors such as the increasing prevalence of UCDs and a surge in product approvals. UCDs are rare, but the growing recognition of their severity and the improvements in diagnostic techniques are leading to a
Rep Id : TMRGL86533 | Published | Healthcare | March 2025
Rising incidence of dysphagia due to the increasing prevalence of neurological conditions such as stroke and Parkinson's disease, growing awareness among healthcare providers and patients about dysphagia, improved diagnostics techniques, and supportive regulatory frameworks aimed at improving care are factors driving the growth of dysphagia management market.
Rep Id : TMRGL86532 | Published | Healthcare | March 2025
The PD-1 Inhibitor Drugs market is influenced by rising incidence of cancer (s), growing usage of immunotherapy, and robust clinical effectiveness of PD-1 inhibitors in treatment of melanoma, lung cancer, and head & neck cancer. Moreover, growth in symptoms outside oncology, advancements in biomarker-directed treatment selection, and growing regulatory approvals
Rep Id : TMRGL86486 | Published | Healthcare | February 2025
The global seborrheic keratosis treatment market is witnessing a steady growth, fueled by rising awareness of dermatological conditions, increasing aesthetic concerns, and technological advancements in non-invasive treatment options.
Rep Id : TMRGL86482 | Published | Healthcare | February 2025
Increasing prevalence of atopic dermatitis in dogs, coupled with rising pet ownership and healthcare spending, are some of the key factors boosting global canine atopic dermatitis market. Chronic pruritus and characteristic skin lesions define atopic dermatitis, often linked to IgE antibodies reacting to environmental allergens in genetically predisposed dogs.
Rep Id : TMRGL86479 | Published | Healthcare | February 2025
The amyloidosis therapeutics market is slated to witness a noticeable growth due to rise in prevalence of amyloidosis, and increase in investments in healthcare infrastructure. Amyloidosis is a rare but severe condition in which abnormal protein deposits, known as amyloidosis, accumulate in organs and tissues, leading to dysfunction.
Rep Id : TMRGL86469 | Published | Healthcare | February 2025
The global compounding pharmacy market is experiencing significant growth due to the increasing demand for hormone replacement therapy (HRT) and the rising adoption of personalized medicine. Additionally, the growing prevalence of chronic diseases that require customized treatment solutions is further driving market expansion.
Rep Id : TMRGL86466 | Published | Healthcare | February 2025
Improved diagnostic techniques and increased awareness of adrenoleukodystrophy (ALD) among healthcare professionals and the public lead to early detection and treatment. Growing research & development activities and patient advocacy and support are factors fueling the global adrenoleukodystrophy drugs market trajectory.
Rep Id : TMRGL86448 | Published | Healthcare | February 2025
The Retinal Vein Occlusion (RVO) market is poised for substantial growth, driven by the increasing prevalence of retinal vein occlusion. Rising awareness about the importance of early diagnosis and advanced treatment options is expected to boost market expansion.
Rep Id : TMRGL60489 | Published | Healthcare | December 2024
The market for treating sickle cell disease (SCD) is seeing substantial growth, driven by breakthroughs in medical research, growing public understanding, and the rise of new treatments. It is anticipated that since therapies including genetic-based approaches, gene-editing methods, and novel medications in the pipeline address the cause rather than the
Rep Id : TMRGL65504 | Published | Healthcare | December 2024
The global viral vectors-based gene therapy for non-human primates market is poised for significant growth, driven by advancements in gene therapy research and increasing demand for preclinical studies. Key drivers to viral vectors-based gene therapy for non-human primates market include the rising prevalence of genetic disorders, infectious diseases, and oncological
Rep Id : TMRGL86394 | Published | Healthcare | September 2024
An exponential increase in the number of patients suffering from cardiovascular diseases is the factor majorly driving the enzyme inhibitor market. Enzyme inhibitors are the molecules interacting with enzymes (permanent or temporary) to reduce rate of an enzyme-catalyzed reaction or avert enzymes to operate in a normal manner.
Rep Id : TMRGL135 | Published | Healthcare | June 2024
Increase in incidence of diabetic retinopathy is a key factor responsible for the vitreous tamponades market growth. Vitreous tamponades or intraocular tamponades are used to avert the flow of intraocular fluid through retinal breaks, thereby helping maintain temporary retinal attachment and letting persistent chorioretinal adhesion appear post application of retinopexy.
Rep Id : TMRGL4233 | Published | Healthcare | April 2024
The surge in aging population globally and awareness regarding the advantages of orthobiologic therapies is fueling the orthobiologics market size. Rise in prevalence of musculoskeletal disorders and sports injuries is driving demand for orthobiologic treatments.
Rep Id : TMRGL1747 | Published | Healthcare | April 2024
Rise in prevalence of chronic disorders and technological advancements in healthcare sector are fueling the apheresis market size. Apheresis helps in blood filtration and purification, thereby being used in various medical treatments conducted for cancers, arthritis, diabetes, and renal diseases.
Rep Id : TMRGL896 | Published | Healthcare | March 2024
Escalating cancer prevalence and the increase in integration of radiation therapy as a key element in cancer treatment is expected to bolster the particle therapy market growth. Technology advancement and ongoing research endeavors have amplified the efficacy and safety of particle therapy, making it an appealing choice for both patients
Rep Id : TMRGL56133 | Published | Healthcare | March 2024
Flowable hemostats help stop bleeding by combining mechanical tamponade effect using hemostatic materials such as gelatin and injectable clotting agents such as thrombin. Fluid hemostatic sealants are absorbable dressings that close tissue and active sources of bleeding such as lymphatics and blood vessels.
Rep Id : TMRGL49347 | Published | Healthcare | February 2024
Oncology nutrition refers to specific dietary plans and interventions designed to address the needs of cancer patients as they suffer from appetite loss, nutrient deficiencies, and weight changes
Rep Id : TMRGL46314 | Published | Healthcare | February 2024
Most comprehensive coverage 100+ countries, 2 million+ data points
Personalized pre-sales, on-boarding, and post-sales support
Less assumption, more science - a research methodology perfected through years of rigorous diligence
True to its name, transparency in every minute details from research processes to financials
20% of Fortune 500 are our clients have worked with over 3000 SMEs
Copyright © Transparency Market Research, Inc. All Rights reserved
Trust Online
